ArticleDiabetology & metabolic syndrome2025
The association of bone mineral density with cardiovascular disease and mortality among individuals with/without type 2 diabetes: a population-based retrospective cohort.
Article in Diabetology & metabolic syndrome, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Human biomarker navigator.iMeta · 2026Review
- Correction: The association of bone mineral density with cardiovascular disease and mortality among individuals with/without type 2 diabetes: a population-based retrospective cohort.Diabetology & metabolic syndrome · 2025Article
Corrections and comments
- Erratum issued
Authors and funding
9 authors.
Funding
Abstract
objectivesWhile type 2 diabetes (T2D) disrupts bone metabolism, T2D individuals often exhibit normal or elevated bone mineral density (BMD), complicating the relationship between BMD and cardiovascular disease (CVD). This study aimed to clarify the associations of BMD with CVD and mortality (CVM) in individuals with/without T2D. STUDY
designa retrospective cohort study.
methodsT2D and non-type 2 diabetes (NT2D) individuals were selected from the National Health and Nutrition Examination Survey (2005-2018). They were classified into three groups based on femoral neck BMD: T1(< 0.8 g/cm²), T2(0.8-1 g/cm²), and T3(≥ 1 g/cm²). Weighted multivariate analysis examined the association between BMD and CVD/CVM, while restricted cubic spline assessed their nonlinearity between BMD and CVM.
resultsThe study comprised 10,586 participants (NT2D: 8,006; T2D: 2,580). During a median follow-up of 125 months, CVD accounted for 201 and 128 deaths in NT2D and T2D groups. After multivariate adjustment, lower BMD was associated with higher CVD risk in the both groups, while higher BMD exhibited lower risk. However, higher BMD in T2D group was linked to increased CVD risk in males[OR
conclusionsWhile low BMD serve as a risk factor for CVD and mortality in NT2D/T2D individuals, high BMD may be associated with elevated cardiovascular risk in T2D patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.